The Latest Breaking News on Pharma

THE turning point was the Brexit referendum. Before voting to leave the EU in June 2016, medicine shortages were not something the UK often had to…

With cures like these, we're glad for modern medicine

The biotech industry flourished amid the pandemic, and lucrative federal investments are expected to drive further growth in the sector. Moreover, amid evolving variants of Coronavirus, the biotech industry is expected to remain in the limelight. Given the sound prospects of the industry, quality biotech stocks Gilead Sciences (GILD) and…

"Maggie’s leadership, compassion and indomitable spirit inspired all around her"

Pharmaceutical company Novartis (NVS) maintained its growth momentum in the third quarter of fiscal 2022, and the company’s growth prospects look promising, supported by its clear focus on five core therapeutic areas, having multiple significant in-market and pipeline assets. Given NVS’ reliable dividend payments and high profitability, this large-cap stock…

There has been little movement towards the roll-out of safe consumption rooms in the 14 months since the Lord Advocate confirmed there was a legal route to pursuing them.

Employers say that noncompete agreements are needed to protect trade secrets and investments. The FTC says they deprive workers of their economic liberties and has proposed a rule to ban them.

Vaccines were built in part on government research and funding, but treatment won’t be free to Americans much longer

The bear market has been downright brutal for growth stocks. Thus making it clear that now is the time for value. That is why you need to discover the attractiveness of Bristol-Myers Squibb (BMY) shares. Read on below for the full story.